- Home
- ANIX vs HYFT Comparison
ANIX vs HYFT Comparison
Compare ANIX & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIX | HYFT |
|---|---|---|
| Founded | 1982 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 93.4M |
| IPO Year | 1987 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ANIX | HYFT |
|---|---|---|
| Price | $3.18 | $2.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 256.6K | ★ 614.8K |
| Earning Date | 01-09-2026 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,019,110.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 49.46 |
| 52 Week Low | $2.12 | $0.27 |
| 52 Week High | $5.46 | $3.25 |
Technical Indicators
Market Signals| Indicator | ANIX | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | N/A |
| Support Level | $3.07 | N/A |
| Resistance Level | $3.36 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 23.08 | 0.00 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.